Found: 105
Select item for more details and to access through your institution.
Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 496, doi. 10.1007/s10637-017-0548-7
- By:
- Publication type:
- Article
Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid–enhanced MRI: long-term follow-up in a surveillance cohort.
- Published in:
- European Radiology, 2022, v. 32, n. 8, p. 5064, doi. 10.1007/s00330-022-08623-8
- By:
- Publication type:
- Article
Clinical impact of preoperative brain MR angiography and MR imaging in candidates for liver transplantation: a propensity score-matching study in a single institution.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Validation and reappraisal of the assessment for retreatment with transarterial chemoembolization score for unresectable non-metastatic hepatocellular carcinoma in a hepatitis b virus-endemic region.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. 497, doi. 10.1159/000525518
- By:
- Publication type:
- Article
Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and Radiotherapy.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 2, p. 152, doi. 10.1159/000521227
- By:
- Publication type:
- Article
The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198138
- By:
- Publication type:
- Article
Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193232
- By:
- Publication type:
- Article
A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid‐Enhanced MRI Features.
- Published in:
- Journal of Magnetic Resonance Imaging, 2022, v. 55, n. 6, p. 1877, doi. 10.1002/jmri.27962
- By:
- Publication type:
- Article
Combined Hepatocellular‐Cholangiocarcinoma: Magnetic Resonance Imaging Features and Prognosis According to Risk Factors for Hepatocellular Carcinoma.
- Published in:
- Journal of Magnetic Resonance Imaging, 2021, v. 53, n. 6, p. 1803, doi. 10.1002/jmri.27528
- By:
- Publication type:
- Article
Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.
- Published in:
- Journal of Magnetic Resonance Imaging, 2015, v. 41, n. 4, p. 1115, doi. 10.1002/jmri.24660
- By:
- Publication type:
- Article
Improving the hepatitis C virus care cascade with the in‐hospital Reflex tEsting ALarm‐C (REAL‐C) model.
- Published in:
- Liver International, 2024, v. 44, n. 5, p. 1243, doi. 10.1111/liv.15877
- By:
- Publication type:
- Article
Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high‐risk patients.
- Published in:
- Liver International, 2022, v. 42, n. 8, p. 2080, doi. 10.1111/liv.15110
- By:
- Publication type:
- Article
Liver Imaging Reporting and Data System categories: Long‐term imaging outcomes in a prospective surveillance cohort.
- Published in:
- Liver International, 2022, v. 42, n. 7, p. 1648, doi. 10.1111/liv.15276
- By:
- Publication type:
- Article
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment‐naïve chronic hepatitis B.
- Published in:
- Liver International, 2022, v. 42, n. 7, p. 1517, doi. 10.1111/liv.15261
- By:
- Publication type:
- Article
Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population‐based study.
- Published in:
- Liver International, 2021, v. 41, n. 11, p. 2777, doi. 10.1111/liv.15011
- By:
- Publication type:
- Article
Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2189, doi. 10.1111/liv.14932
- By:
- Publication type:
- Article
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular‐cholangiocarcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1398, doi. 10.1111/liv.14813
- By:
- Publication type:
- Article
Surgical resection versus radiofrequency ablation very early‐stage HCC (≤2 cm Single HCC): A propensity score analysis.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. 2397, doi. 10.1111/liv.14258
- By:
- Publication type:
- Article
Long‐term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country.
- Published in:
- Liver International, 2019, v. 39, n. 5, p. 985, doi. 10.1111/liv.14082
- By:
- Publication type:
- Article
Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue.
- Published in:
- Liver International, 2018, v. 38, n. 3, p. 503, doi. 10.1111/liv.13555
- By:
- Publication type:
- Article
New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization.
- Published in:
- Liver International, 2017, v. 37, n. 12, p. 1861, doi. 10.1111/liv.13487
- By:
- Publication type:
- Article
The impact of hepatitis C virus outside the liver: Evidence from Asia.
- Published in:
- Liver International, 2017, v. 37, n. 2, p. 159, doi. 10.1111/liv.13272
- By:
- Publication type:
- Article
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study.
- Published in:
- Liver International, 2016, v. 36, n. 10, p. 1433, doi. 10.1111/liv.13128
- By:
- Publication type:
- Article
Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
- Published in:
- Liver International, 2016, v. 36, n. 9, p. 1351, doi. 10.1111/liv.13099
- By:
- Publication type:
- Article
Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns.
- Published in:
- Hepatology Research, 2013, v. 43, n. 12, p. 1304, doi. 10.1111/hepr.12083
- By:
- Publication type:
- Article
Clinical Usefulness of Endoscopic Palliation in Patients with Biliary Obstruction Caused by Hepatocellular Carcinoma.
- Published in:
- Digestion, 2013, v. 88, n. 2, p. 87, doi. 10.1159/000353200
- By:
- Publication type:
- Article
Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients.
- Published in:
- Drug Design, Development & Therapy, 2022, v. 16, p. 3263, doi. 10.2147/DDDT.S376821
- By:
- Publication type:
- Article
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097934
- By:
- Publication type:
- Article
Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 119, doi. 10.1159/000336082
- By:
- Publication type:
- Article
Transforming Growth Factor Beta 1 Overexpression Is Closely Related to Invasiveness of Hepatocellular Carcinoma.
- Published in:
- Oncology, 2012, v. 82, n. 1, p. 11, doi. 10.1159/000335605
- By:
- Publication type:
- Article
Safety, pharmacokinetics and antiviral activity of ABI‐H2158, a hepatitis B virus core inhibitor: A randomized, placebo‐controlled phase 1 study.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 3, p. 209, doi. 10.1111/jvh.13764
- By:
- Publication type:
- Article
Use of hepatitis B virus DNA and liver stiffness in predicting clinical events in patients with chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 4, p. 297, doi. 10.1111/jvh.13648
- By:
- Publication type:
- Article
A risk scoring system to predict clinical events in chronic hepatitis B virus infection: A nationwide cohort study.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 2, p. 115, doi. 10.1111/jvh.13631
- By:
- Publication type:
- Article
Tenofovir disoproxil fumarate on the risk of hepatocellular carcinoma in chronic hepatitis B patients with failure to preceding treatments: A nationwide cohort study.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 8, p. 1150, doi. 10.1111/jvh.13530
- By:
- Publication type:
- Article
High level of medication adherence is required to lower mortality in patients with chronic hepatitis B taking entecavir: A nationwide cohort study.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 2, p. 353, doi. 10.1111/jvh.13418
- By:
- Publication type:
- Article
Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health‐related quality of life in East Asian patients with hepatitis C virus infection.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 12, p. 1429, doi. 10.1111/jvh.12965
- By:
- Publication type:
- Article
CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1223, doi. 10.1111/apt.17933
- By:
- Publication type:
- Article
Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 4, p. 515, doi. 10.1111/apt.17819
- By:
- Publication type:
- Article
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 217, doi. 10.1111/apt.17764
- By:
- Publication type:
- Article
Editorial: Time to consider early treatment for chronic hepatitis B in both children and adults.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 3, p. 519, doi. 10.1111/apt.17052
- By:
- Publication type:
- Article
Editorial: does TAF have a better or worse safety profile than TDF, to treat hepatitis B? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 8, p. 1044, doi. 10.1111/apt.16886
- By:
- Publication type:
- Article
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 8, p. 921, doi. 10.1111/apt.16788
- By:
- Publication type:
- Article
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B—authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 6, p. 763, doi. 10.1111/apt.16278
- By:
- Publication type:
- Article
East Asia expert opinion on treatment initiation for chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 10, p. 1540, doi. 10.1111/apt.16097
- By:
- Publication type:
- Article
Letter: moderate levels of serum hepatitis B virus DNA alone are not associated with increased risk of hepatocellular carcinoma in chronic hepatitis B patients. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 576, doi. 10.1111/apt.15881
- By:
- Publication type:
- Article
Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg‐positive versus HBeAg‐negative patients. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1440, doi. 10.1111/apt.15794
- By:
- Publication type:
- Article
Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1169, doi. 10.1111/apt.15725
- By:
- Publication type:
- Article